MacroGenics
MGNX
#8794
Rank
A$0.34 B
Marketcap
A$5.35
Share price
5.35%
Change (1 day)
105.04%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): A-$0.85

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.82. In 2025 the company made an earnings per share (EPS) of A-$1.69 a decrease over its 2024 EPS that were of A-$1.53.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.85-49.8%
2025A-$1.6910.28%
2024A-$1.53613.33%
2023A-$0.21-92.31%
2022A-$2.79-42.14%
2021A-$4.8236.44%
2020A-$3.53-21.84%
2019A-$4.52-24.58%
2018A-$6.00675.93%
2017A-$0.77-68.05%
2016A-$2.42168.25%
2015A-$0.90-55%
2014A-$2.003400%
2013A-$0.05724-108.68%
2012A$0.6624.49%
2011A$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.09-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.77-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.21-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$3.72 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.81-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.50-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$3.11 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA